Related Experiment Videos
[Platelet activation in obstructive sleep apnea syndrome].
1Tokai University School of Medicine, Department of Pulmonary Medicine, 143 Shimokasuya, Isehara, Kanagawa, Japan.
Summary
Obstructive sleep apnea (OSA) is linked to higher cardiovascular risks. This study found increased activated platelet markers, PAC-1 and CD62P, in OSA patients, suggesting they indicate disease severity.
Area of Science:
- Cardiovascular Physiology
- Hematology
- Sleep Medicine
Context:
- Obstructive sleep apnea (OSA) is associated with increased risks of cardiovascular and cerebrovascular diseases.
- The underlying mechanisms linking OSA to these conditions are not fully understood.
- Activated platelets are implicated in various pathological conditions, including stroke and ischemic heart disease.
Purpose:
- To investigate whether markers of platelet activation are elevated in patients with obstructive sleep apnea (OSA) compared to healthy subjects.
- To explore the correlation between platelet activation markers and OSA severity.
Summary:
- This study measured PAC-1 and CD62P, markers of activated platelets, in 20 male OSA patients and 12 healthy male subjects using flow cytometry.
- OSA patients exhibited significantly higher PAC-1 (65.1% vs. 16.8%) and CD62P (8.5% vs. 0.88%) expression compared to healthy controls.
- Increased PAC-1 expression correlated with the apnea-hypopnea index (AHI) and arousal index in OSA patients.
Impact:
- Findings suggest that elevated PAC-1 and CD62P levels may serve as valuable indicators for untreated obstructive sleep apnea.
- This research opens avenues for understanding the role of platelet activation in OSA pathophysiology.
- Identifying reliable biomarkers could aid in risk stratification and management of OSA patients.